Advanced Pharmacology Clinical
Final Examination (2026 Update)||
questions and answers with
rationales/graded A+/2026
update/100% correct /instant
download
Total Questions: 85
Format: Multiple Choice
Instructions: Select the best answer. Correct answers are highlighted in bold with
a rationale provided.
Section 1: Cardiovascular Pharmacology (Questions 1-15)
1. A 62-year-old male with HFrEF (EF 30%) on maximal guideline-directed
therapy presents with persistent fatigue and an eGFR of 35 mL/min. Which agent
is MOST appropriate to add to reduce cardiovascular death?
A) Digoxin 0.125 mg daily
B) Sodium-glucose cotransporter-2 inhibitor (dapagliflozin) – Rationale:
SGLT2i reduce HF hospitalization and CV death in HFrEF regardless of diabetes
status, even with moderate CKD.
C) Spironolactone 50 mg daily
D) Hydralazine/isosorbide dinitrate
2. A patient on warfarin for atrial fibrillation has an INR of 4.5 without bleeding.
Their medication list includes amiodarone started 2 weeks ago. What is the most
likely cause?
A) Amiodarone-induced warfarin resistance
,B) Amiodarone inhibits CYP2C9 and CYP1A2, increasing warfarin
effect – Rationale: Amiodarone significantly potentiates warfarin; INR should be
monitored weekly upon initiation.
C) Laboratory error
D) Dietary vitamin K excess
3. Which antiarrhythmic drug is contraindicated in a patient with a history of
torsades de pointes?
A) Lidocaine
B) Dofetilide – Rationale: Class III agents (dofetilide, sotalol) prolong QT interval
and can precipitate torsades.
C) Mexiletine
D) Flecainide
4. A 55-year-old with acute decompensated HF is started on IV nitroglycerin. After
4 hours, BP drops to 85/50 mmHg. What is the next best step?
A) Increase nitroglycerin rate
B) Start norepinephrine – Rationale: Nitroglycerin causes venodilation and
arterial dilation; persistent hypotension requires vasopressor support after
ensuring adequate volume.
C) Administer furosemide 80 mg IV
D) Give metoprolol 25 mg orally
5. A patient with STEMI receives ticagrelor loading dose. Which concomitant
medication would cause major concern?
A) Omeprazole
B) Aspirin 81 mg
C) Rifampin – Rationale: Rifampin is a strong CYP3A4 inducer, reducing
ticagrelor efficacy and increasing thrombotic risk.
D) Atorvastatin
6. Which antihypertensive agent is preferred in a 30-year-old pregnant woman with
chronic hypertension?
A) Lisinopril
B) Valsartan
C) Labetalol – Rationale: Labetalol (beta-blocker) and nifedipine are first-line in
pregnancy; ACEi/ARBs are teratogenic.
D) Hydrochlorothiazide
, 7. A patient on rosuvastatin 40 mg presents with diffuse myalgia and a CK level of
8,000 U/L. What is the most appropriate immediate step?
A) Switch to pravastatin
B) Discontinue rosuvastatin and monitor renal function – Rationale: Likely
statin-induced rhabdomyolysis; immediate cessation is required to prevent acute
kidney injury.
C) Add coenzyme Q10
D) Continue rosuvastatin but reduce to 20 mg
8. Which anticoagulant reversal agent is correctly paired?
A) Warfarin – Andexanet alfa
B) Dabigatran – Idarucizumab – Rationale: Idarucizumab is a monoclonal
antibody fragment specific to dabigatran.
C) Rivaroxaban – Vitamin K
D) Apixaban – Protamine sulfate
9. A 70-year-old with non-valvular AF and CHA₂DS₂-VASc score of 5 has a
creatinine clearance of 28 mL/min. Which DOAC is most appropriate?
A) Dabigatran 150 mg BID
B) Apixaban 5 mg BID – *Rationale: Apixaban is safe in CrCl 25-30 mL/min;
rivaroxaban and edoxaban require dose adjustment, dabigatran is contraindicated if
CrCl <30.*
C) Rivaroxaban 20 mg daily
D) Edoxaban 60 mg daily
10. Which beta-blocker has the greatest mortality benefit in chronic HFrEF?
A) Atenolol
B) Carvedilol – Rationale: Carvedilol, metoprolol succinate, and bisoprolol are
evidence-based; carvedilol has additional alpha-blockade and antioxidant effects.
C) Propranolol
D) Esmolol
11. A patient develops clopidogrel resistance post-stent. Genotyping reveals
CYP2C19*2/*2. Which alternative is best?
A) Aspirin 325 mg daily
B) Ticagrelor 90 mg BID – Rationale: Ticagrelor is not dependent on CYP2C19
activation, unlike clopidogrel.
C) Prasugrel 10 mg daily
D) Cilostazol
Final Examination (2026 Update)||
questions and answers with
rationales/graded A+/2026
update/100% correct /instant
download
Total Questions: 85
Format: Multiple Choice
Instructions: Select the best answer. Correct answers are highlighted in bold with
a rationale provided.
Section 1: Cardiovascular Pharmacology (Questions 1-15)
1. A 62-year-old male with HFrEF (EF 30%) on maximal guideline-directed
therapy presents with persistent fatigue and an eGFR of 35 mL/min. Which agent
is MOST appropriate to add to reduce cardiovascular death?
A) Digoxin 0.125 mg daily
B) Sodium-glucose cotransporter-2 inhibitor (dapagliflozin) – Rationale:
SGLT2i reduce HF hospitalization and CV death in HFrEF regardless of diabetes
status, even with moderate CKD.
C) Spironolactone 50 mg daily
D) Hydralazine/isosorbide dinitrate
2. A patient on warfarin for atrial fibrillation has an INR of 4.5 without bleeding.
Their medication list includes amiodarone started 2 weeks ago. What is the most
likely cause?
A) Amiodarone-induced warfarin resistance
,B) Amiodarone inhibits CYP2C9 and CYP1A2, increasing warfarin
effect – Rationale: Amiodarone significantly potentiates warfarin; INR should be
monitored weekly upon initiation.
C) Laboratory error
D) Dietary vitamin K excess
3. Which antiarrhythmic drug is contraindicated in a patient with a history of
torsades de pointes?
A) Lidocaine
B) Dofetilide – Rationale: Class III agents (dofetilide, sotalol) prolong QT interval
and can precipitate torsades.
C) Mexiletine
D) Flecainide
4. A 55-year-old with acute decompensated HF is started on IV nitroglycerin. After
4 hours, BP drops to 85/50 mmHg. What is the next best step?
A) Increase nitroglycerin rate
B) Start norepinephrine – Rationale: Nitroglycerin causes venodilation and
arterial dilation; persistent hypotension requires vasopressor support after
ensuring adequate volume.
C) Administer furosemide 80 mg IV
D) Give metoprolol 25 mg orally
5. A patient with STEMI receives ticagrelor loading dose. Which concomitant
medication would cause major concern?
A) Omeprazole
B) Aspirin 81 mg
C) Rifampin – Rationale: Rifampin is a strong CYP3A4 inducer, reducing
ticagrelor efficacy and increasing thrombotic risk.
D) Atorvastatin
6. Which antihypertensive agent is preferred in a 30-year-old pregnant woman with
chronic hypertension?
A) Lisinopril
B) Valsartan
C) Labetalol – Rationale: Labetalol (beta-blocker) and nifedipine are first-line in
pregnancy; ACEi/ARBs are teratogenic.
D) Hydrochlorothiazide
, 7. A patient on rosuvastatin 40 mg presents with diffuse myalgia and a CK level of
8,000 U/L. What is the most appropriate immediate step?
A) Switch to pravastatin
B) Discontinue rosuvastatin and monitor renal function – Rationale: Likely
statin-induced rhabdomyolysis; immediate cessation is required to prevent acute
kidney injury.
C) Add coenzyme Q10
D) Continue rosuvastatin but reduce to 20 mg
8. Which anticoagulant reversal agent is correctly paired?
A) Warfarin – Andexanet alfa
B) Dabigatran – Idarucizumab – Rationale: Idarucizumab is a monoclonal
antibody fragment specific to dabigatran.
C) Rivaroxaban – Vitamin K
D) Apixaban – Protamine sulfate
9. A 70-year-old with non-valvular AF and CHA₂DS₂-VASc score of 5 has a
creatinine clearance of 28 mL/min. Which DOAC is most appropriate?
A) Dabigatran 150 mg BID
B) Apixaban 5 mg BID – *Rationale: Apixaban is safe in CrCl 25-30 mL/min;
rivaroxaban and edoxaban require dose adjustment, dabigatran is contraindicated if
CrCl <30.*
C) Rivaroxaban 20 mg daily
D) Edoxaban 60 mg daily
10. Which beta-blocker has the greatest mortality benefit in chronic HFrEF?
A) Atenolol
B) Carvedilol – Rationale: Carvedilol, metoprolol succinate, and bisoprolol are
evidence-based; carvedilol has additional alpha-blockade and antioxidant effects.
C) Propranolol
D) Esmolol
11. A patient develops clopidogrel resistance post-stent. Genotyping reveals
CYP2C19*2/*2. Which alternative is best?
A) Aspirin 325 mg daily
B) Ticagrelor 90 mg BID – Rationale: Ticagrelor is not dependent on CYP2C19
activation, unlike clopidogrel.
C) Prasugrel 10 mg daily
D) Cilostazol
